| Pre-ART visit week 2 of fluconazole | Week 4 of HIV therapy week 6 of fluconazole | Intra-person change |  | |||
---|---|---|---|---|---|---|---|
Population Characteristics | Average | SD | Average | SD | Change | SD | P-value |
CD4 count (cells/uL), N = 60 | 32 | ±30 | 80 | ±74 | 47 | ±66 | <0.001 |
Karnofsky score, N = 73 | 72 | ±12 | 75 | ±11 | 2.5 | ±10 | 0.04 |
CES depression scale, N = 73 | 19 | ±10 | 16 | ±10 | −3.0 | ±12 | 0.04 |
Neurocognitive Tests | |||||||
 Symbol digit modalities | −1.9 | ±1.2 | −1.5 | ±1.5 | 0.4 | ±1.0 | 0.002 |
 Grooved pegboard dominant | −0.3 | ±1.3 | 0.1 | ±1.1 | 0.4 | ±1.4 | 0.02 |
 Grooved pegboard non-dominant | −0.4 | ±1.5 | -0.02 | ±1.3 | 0.3 | ±1.3 | 0.03 |
 Color Trails 1 | −2.4 | ±2.6 | −1.0 | ±1.7 | 1.4 | ±2.3 | <0.001 |
 Color Trails 2 | −3.7 | ±2.6 | −1.9 | ±1.6 | 1.7 | ±2.1 | <0.001 |
 Digit span forward | −0.5 | ±0.9 | −0.3 | ±0.9 | 0.2 | ±0.9 | 0.15 |
 Digit span backward | −1.4 | ±1.4 | −1.1 | ±1.3 | 0.3 | ±1.2 | 0.03 |
 Auditory verbal learning | −2.2 | ±1.4 | −1.2 | ±1.5 | 1.0 | ±1.2 | <0.001 |
 Verbal fluency | −0.9 | ±0.7 | −0.6 | ±0.7 | 0.3 | ±0.7 | 0.005 |
 Finger tapping | −2.3 | ±1.1 | −1.9 | ±1.0 | 0.4 | ±1.1 | 0.002 |
 QNPZ-8 | -1.7 | ±1.0 | −1.0 | ±0.8 | 0.7 | ±0.7 | <0.001 |